{
    "Trade/Device Name(s)": [
        "VITROS XT Chemistry Products TRIG-CHOL Slides"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K190490",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130332",
        "K820263"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CDT",
        "CHH"
    ],
    "Summary Letter Date": "February 27, 2019",
    "Summary Letter Received Date": "February 28, 2019",
    "Submission Date": "March 22, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1705",
        "21 CFR 862.1175"
    ],
    "Regulation Name(s)": [
        "Triglyceride test system",
        "Cholesterol (total) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Triglyceride",
        "Cholesterol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITROS XT 7600 Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric assay",
        "Reflectance spectrophotometry"
    ],
    "Methodologies": [
        "Colorimetric quantification"
    ],
    "Submission Type(s)": [
        "Slide"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS XT Chemistry Products TRIG-CHOL Slides for quantitative measurement of triglycerides and cholesterol in serum and plasma using colorimetric technology on VITROS XT 7600 Integrated System",
    "Indications for Use Summary": "Quantitative measurement of triglyceride and cholesterol concentrations in serum and plasma for diagnosis and treatment of lipid metabolism disorders, diabetes mellitus, nephrosis, liver and renal diseases, and atherosclerosis",
    "fda_folder": "Clinical Chemistry"
}